Patrick Avenet
Overview
Explore the profile of Patrick Avenet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
401
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Griebel G, Pichat P, Beeske S, Leroy T, Redon N, Jacquet A, et al.
Sci Rep
. 2015 Jan;
5:7642.
PMID: 25560837
Monoacylglycerol lipase (MAGL) represents a primary degradation enzyme of the endogenous cannabinoid (eCB), 2-arachidonoyglycerol (2-AG). This study reports a potent covalent MAGL inhibitor, SAR127303. The compound behaves as a selective...
2.
Griebel G, Ravinet-Trillou C, Beeske S, Avenet P, Pichat P
Front Endocrinol (Lausanne)
. 2014 May;
5:49.
PMID: 24782829
Disruption of circadian clock enhances the risk of metabolic syndrome, obesity, and type 2 diabetes. Circadian clocks rely on a highly regulated network of transcriptional and translational loops that drive...
3.
Hortala L, Arnaud J, Roux P, Oustric D, Boulu L, Oury-Donat F, et al.
Bioorg Med Chem Lett
. 2013 Dec;
24(1):283-7.
PMID: 24291040
Cannabinoid CB2 PET tracers are considered as a promising alternative to PBR/TSPO tracers for the in-vivo imaging of neuroinflammation. We describe here the synthesis and characterization of compound 3, a...
4.
Boulay D, Ho-Van S, Bergis O, Avenet P, Griebel G
Behav Pharmacol
. 2013 Aug;
24(7):543-51.
PMID: 23928693
The objective of the present study was to examine the idea that the decrease in 50-kHz ultrasonic vocalizations elicited by tickling in juvenile rats following the administration of the psychotomimetic...
5.
Griebel G, Beeske S, Jacquet A, Laufrais C, Alonso R, Decobert M, et al.
Neuropharmacology
. 2013 Jan;
70:19-26.
PMID: 23321054
5-Hydroxytryptamine (5-HT)2A antagonists are promising therapeutic agents for the treatment of sleep maintenance insomnias, but unlike hypnotics, they have limited effects on sleep initiation. This study evaluated the effects of...
6.
Boulay D, Bergis O, Avenet P, Griebel G
Neuropsychopharmacology
. 2009 Sep;
35(2):416-27.
PMID: 19759529
Schizophrenia has been initially associated with dysfunction in dopamine neurotransmission. However, the observation that antagonists of the glutamate N-methyl-D-aspartate (NMDA) receptor produce schizophrenic-like symptoms in humans has led to the...
7.
Boulay D, Pichat P, Dargazanli G, Estenne-Bouhtou G, Terranova J, Rogacki N, et al.
Pharmacol Biochem Behav
. 2008 Jul;
91(1):47-58.
PMID: 18621075
On native human, rat and mouse glycine transporter-1(GlyT1), SSR130800 behaves as a selective inhibitor with IC50 values of 1.9, 5.3 and 6.8 nM, respectively. It reversibly blocked glycine uptake in...
8.
Stemmelin J, Cohen C, Terranova J, Lopez-Grancha M, Pichat P, Bergis O, et al.
Neuropsychopharmacology
. 2007 Apr;
33(3):574-87.
PMID: 17460614
The characterization of the first selective orally active and brain-penetrant beta3-adrenoceptor agonist, SR58611A (amibegron), has opened new possibilities for exploring the involvement of this receptor in stress-related disorders. By using...
9.
Biton B, Bergis O, Galli F, Nedelec A, Lochead A, Jegham S, et al.
Neuropsychopharmacology
. 2006 Oct;
32(1):1-16.
PMID: 17019409
In this paper, we report on the pharmacological and functional profile of SSR180711 (1,4-Diazabicyclo[3.2.2]nonane-4-carboxylic acid, 4-bromophenyl ester), a new selective alpha7 acetylcholine nicotinic receptor (n-AChRs) partial agonist. SSR180711 displays high...
10.
Pichat P, Bergis O, Terranova J, Urani A, Duarte C, Santucci V, et al.
Neuropsychopharmacology
. 2006 Aug;
32(1):17-34.
PMID: 16936709
SSR180711 (4-bromophenyl 1,4diazabicyclo(3.2.2) nonane-4-carboxylate, monohydrochloride) is a selective alpha7 nicotinic receptor (n-AChR) partial agonist. Based on the purported implication of this receptor in cognitive deficits associated with schizophrenia, the present...